Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum International Stem Cell Corp ISCO

International Stem Cell Corporation is a clinical-stage biotechnology company that is focused on therapeutic and biomedical product development. The Company is primarily a research and development company, for the therapeutic market, which has focused on advancing potential clinical applications of human parthenogenetic stem cells (hpSCs) for the treatment of various diseases of the central... see more

Bullboard (OTCQB:ISCO)

View:
Post by MissionIRon Feb 26, 2016 4:45pm

International Stem Cell Corp. (ISCO) Building Value through

International Stem Cell Corp. (ISCO) Building Value through Development of Therapeutics for Parkinson’s Disease   International Stem Cell Corp. (OTCQB: ISCO) is considered among industry ...more  
Post by MissionIRon Feb 17, 2016 3:52pm

International Stem Cell Corp. (ISCO) Provides Hope for Parki

International Stem Cell Corp. (ISCO) Provides Hope for Parkinson’s Patients with Ethical Stem Cell Development   Parkinson’s disease is caused by death of dopamine-producing cells in a brain ...more  
Post by MissionIRon Feb 09, 2016 3:53pm

International Stem Cell Corp. (ISCO) Eyes Growth through Par

International Stem Cell Corp. (ISCO) Eyes Growth through Partnerships to Develop Therapeutic and Biomedical Products Worldwide    International Stem Cell Corp. (OTCQB: ISCO) builds ...more  
Post by MissionIRon Feb 02, 2016 6:41pm

International Stem Cell Corporation (ISCO) Continues Upward

International Stem Cell Corporation (ISCO) Continues Upward Climb toward Changing the Face of Regenerative Medicine   A California-based biotechnology company, International Stem Cell ...more  
Post by MissionIRon Jan 20, 2016 5:04pm

International Stem Cell Corp. (ISCO) Developing Therapeutic

International Stem Cell Corp. (ISCO) Developing Therapeutic Products from Its Own Intellectual Property    As part of its quest to successfully develop stem cells for research and ...more  
Post by MissionIRon Jan 13, 2016 3:55pm

International Stem Cell Corporation (ISCO) – Florey Clinical

International Stem Cell Corporation (ISCO) – Florey Clinical Service Agreement Expected to Deliver Results Later this Year    International Stem Cell Corporation (OTCQB: ISCO), a ...more  
Post by MissionIRon Jan 11, 2016 6:17pm

International Stem Cell Corporation (ISCO) may be Running a

International Stem Cell Corporation (ISCO) may be Running a Loss, but it’s also Making a Profit    International Stem Cell Corporation (OTCQB: ISCO) has its fingers in many pies. It ...more  
Post by MissionIRon Dec 28, 2015 5:00pm

International Stem Cell Corp. (ISCO) Edges Ever Closer to Fi

International Stem Cell Corp. (ISCO) Edges Ever Closer to First Real Therapeutic Solution for Halting & Even Reversing Parkinson’s    With the recent announcement from Australia’s ...more  
Post by MissionIRon Dec 23, 2015 3:44pm

International Stem Cell Corp. (ISCO) to Conduct Clinical Tri

International Stem Cell Corp. (ISCO) to Conduct Clinical Trial with One of the World’s Leading Brain Research Centers   International Stem Cell Corp., a clinical stage biotech company ...more  
Post by MissionIRon Dec 17, 2015 7:47pm

International Stem Cell Corporation’s (ISCO) Clinical Trials

International Stem Cell Corporation’s (ISCO) Clinical Trials Vital to Halting Progression of Parkinson’s Disease    Parkinson’s disease is a progressive movement disorder, meaning that ...more  
Post by MissionIRon Dec 14, 2015 3:27pm

International Stem Cell Corp. (ISCO) Gets Regulatory Green L

International Stem Cell Corp. (ISCO) Gets Regulatory Green Light to Begin Clinical Trial of ISC-hpNSC for the Treatment of Parkinson’s Disease    Currently available Parkinson’s disease ...more  
Post by MissionIRon Dec 08, 2015 6:02pm

International Stem Cell Corp. (ISCO) Has a Broad Pipeline of

International Stem Cell Corp. (ISCO) Has a Broad Pipeline of Targets    International Stem Cell Corp. is tackling some of the world’s most debilitating health maladies with a powerful ...more  
Post by MissionIRon Dec 01, 2015 4:16pm

International Stem Cell Corp. (ISCO) to Launch New, Highly L

International Stem Cell Corp. (ISCO) to Launch New, Highly Lauded Skincare Product this Holiday Season    International Stem Cell Corp., a California-based biotech developing novel stem ...more  
Post by MissionIRon Nov 30, 2015 6:07pm

International Stem Cell Corporation (ISCO) Uses Multiple Bus

International Stem Cell Corporation (ISCO) Uses Multiple Business Units to Generate Even More Revenue   International Stem Cell Corporation (OTC: ISCO) focuses on utilizing patented human ...more  
Post by MissionIRon Nov 23, 2015 8:14pm

International Stem Cell Corp. (ISCO) Injection of Ethically-

International Stem Cell Corp. (ISCO) Injection of Ethically-Derived Neural Stem Cells for the Treatment of Parkinson’s to Be Tested in Australia   The true forefront in medicine today is a ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities